Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 Pipeline Review, H1 2018
Summary
Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 Basic fibroblast growth factor also known as bFGF or FGF2 is a member of the fibroblast growth factor family. This protein plays an important role in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. Diseases associated with FGF2 include corneal neovascularization and pulmonary capillary hemangiomatosis.
Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II and Preclinical stages are 2 and 4 respectively. Similarly, the universities portfolio in Preclinical stages comprises 3 molecules, respectively.
Report covers products from therapy areas Oncology, Cardiovascular, Metabolic Disorders, Ophthalmology, Central Nervous System, Immunology, Musculoskeletal Disorders and Respiratory which include indications Breast Cancer, Critical Limb Ischemia, Melanoma, Pancreatic Cancer, Achondroplasia, Age Related Macular Degeneration, Angina Angina Pectoris, Bone Disorders, Cancer Pain, Colon Cancer, Diabetic Macular Edema, Gallbladder Cancer, Gastric Cancer, Glioblastoma Multiforme GBM, Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis, Intermittent Claudication, Lung Cancer, Lymphoma, Osteoporosis, Ovarian Cancer, Peripheral Arterial Disease PAD/ Peripheral Vascular Disease PVD, Proliferative Diabetic Retinopathy PDR, Prostate Cancer, Retinal Vein Occlusion and Rheumatoid Arthritis.
The latest report Fibroblast Growth Factor 2 Pipeline Review, H1 2018, outlays comprehensive information on the Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type. It also reviews key players involved in Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 targeted therapeutics development with respective active and dormant or discontinued projects.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
The report provides a snapshot of the global therapeutic landscape for Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2
The report reviews Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources
The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities
The report reviews key players involved in Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 targeted therapeutics and enlists all their major and minor projects
The report assesses Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 targeted therapeutics
Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Fibroblast Growth Factor 2 Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2 development landscape
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope